GlassScriptPhysician profile
Felicia A Bertram
NPI 1326155573
$1,863.21
in general payments reported to CMS, 2019-2025
19 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $547 · 2022: $234 · 2023: $369 · 2024: $506 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930 · Education: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.74 |
| Education | $152.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $501.46 | 2021-2025 | Xtampza |
| Scilex Pharmaceuticals INC. | $254.99 | 2021-2025 | Ztlido |
| Ipsen Biopharmaceuticals, INC | $220.23 | 2024 | Dysport |
| Biohaven Pharmaceutical Holding Company LTD. | $140.44 | 2022 | |
| Nevro Corp. | $131.08 | 2021 | |
| Painteq LLC | $110.46 | 2022-2023 | Painteq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.32 | 2021 | |
| Globus Medical, INC. | $70.70 | 2025 | Senza |
| Tersera Therapeutics LLC | $58.78 | 2022-2025 | Prialt |
| Virtus Pharmaceuticals LLC | $55.42 | 2021 | |
| Boston Scientific Corporation | $43.40 | 2023 | Wavewriter Alpha Prime 16 |
| Vertex Pharmaceuticals Incorporated | $42.70 | 2024-2025 | |
| Fidia Pharma USA INC. | $42.66 | 2021 | |
| Abbvie INC. | $23.94 | 2021 | |
| Abbott Laboratories | $23.73 | 2024 | Immunalysis Corporation |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $20.36 | 2024 | Mild Device Kit |
| Ibsa Pharma INC. | $13.68 | 2021 | |
| Biodelivery Sciences International, INC. | $13.60 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felicia Bertram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.